Literature DB >> 7494551

Progression of heart failure: a role for interstitial fibrosis.

H N Sabbah1, V G Sharov, M Lesch, S Goldstein.   

Abstract

Progressive deterioration of left ventricular (LV) function is a characteristic feature of the heart failure (HF) state. The mechanism or mechanisms responsible for this hemodynamic deterioration are not known but may be related to progressive intrinsic dysfunction, degeneration and loss of viable cardiocytes. In the present study, we tested the hypothesis that accumulation of collagen in the cardiac interstitium (reactive interstitial fibrosis, RIF), known to occur in HF, results in reduced capillary density (CD = capillary/fiber ratio) and increased oxygen diffusion distance (ODD) which can lead to hypoxia and dysfunction of the collagen encircled myocyte. Studies were performed in LV tissue obtained from 10 dogs with chronic HF (LV ejection fraction 26 +/- 1%) produced by multiple sequential intracoronary microembolizations. In each dog, CD and ODD were evaluated in LV regions that manifested severe RIF (volume fraction 16 +/- 2%) and in LV regions of little or no RIF (volume fraction 4 +/- 1%). In regions of severe RIF, CD was significantly decreased compared to regions of no RIF (0.92 +/- 0.02 vs. 1.05 +/- 0.03) (P < 0.003). Similarly, ODD was significantly increased in regions of severe RIF compared to regions of no RIF (15.3 +/- 0.4 vs. 12.2 +/- 0.3 microns) (P < 0.001). These data suggest that in dogs with chronic HF, constituent myocytes of LV regions which manifest severe RIF may be subjected to chronic hypoxia; a condition that can adversely impact the function and viability of the collagen encircled cardiocyte.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7494551     DOI: 10.1007/bf00944780

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  21 in total

Review 1.  Development, early treatment, and prevention of heart failure. Introduction.

Authors:  G Ertl; K Kochsiek
Journal:  Circulation       Date:  1993-05       Impact factor: 29.690

2.  Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dysfunction in patients with heart failure. SOLVD Investigators.

Authors:  M A Konstam; M F Rousseau; M W Kronenberg; J E Udelson; J Melin; D Stewart; N Dolan; T R Edens; S Ahn; D Kinan
Journal:  Circulation       Date:  1992-08       Impact factor: 29.690

3.  The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure.

Authors:  M Packer
Journal:  J Am Coll Cardiol       Date:  1992-07       Impact factor: 24.094

4.  Role of the renin-angiotensin system in the systemic vasoconstriction of chronic congestive heart failure.

Authors:  C Curtiss; J N Cohn; T Vrobel; J A Franciosa
Journal:  Circulation       Date:  1978-11       Impact factor: 29.690

5.  Mitochondrial abnormalities in myocardium of dogs with chronic heart failure.

Authors:  H N Sabbah; V Sharov; J M Riddle; T Kono; M Lesch; S Goldstein
Journal:  J Mol Cell Cardiol       Date:  1992-11       Impact factor: 5.000

6.  Adrenergic effects on the biology of the adult mammalian cardiocyte.

Authors:  D L Mann; R L Kent; B Parsons; G Cooper
Journal:  Circulation       Date:  1992-02       Impact factor: 29.690

7.  Reactive and reparative myocardial fibrosis in arterial hypertension in the rat.

Authors:  C G Brilla; K T Weber
Journal:  Cardiovasc Res       Date:  1992-07       Impact factor: 10.787

8.  Griffonia simplicifolia I: fluorescent tracer for microcirculatory vessels in nonperfused thin muscles and sectioned muscle.

Authors:  F M Hansen-Smith; L Watson; D Y Lu; I Goldstein
Journal:  Microvasc Res       Date:  1988-11       Impact factor: 3.514

Review 9.  Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system.

Authors:  K T Weber; C G Brilla
Journal:  Circulation       Date:  1991-06       Impact factor: 29.690

10.  Cardiac myocyte necrosis induced by angiotensin II.

Authors:  L B Tan; J E Jalil; R Pick; J S Janicki; K T Weber
Journal:  Circ Res       Date:  1991-11       Impact factor: 17.367

View more
  47 in total

1.  Heterogeneous myocyte enhancer factor-2 (Mef2) activation in myocytes predicts focal scarring in hypertrophic cardiomyopathy.

Authors:  Tetsuo Konno; Dan Chen; Libin Wang; Hiroko Wakimoto; Polakit Teekakirikul; Matthew Nayor; Masataka Kawana; Seda Eminaga; Joshua M Gorham; Kumar Pandya; Oliver Smithies; Francisco J Naya; Eric N Olson; J G Seidman; Christine E Seidman
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-05       Impact factor: 11.205

2.  Augmentation of left ventricular wall thickness with alginate hydrogel implants improves left ventricular function and prevents progressive remodeling in dogs with chronic heart failure.

Authors:  Hani N Sabbah; Mengjun Wang; Ramesh C Gupta; Sharad Rastogi; Itamar Ilsar; Michael S Sabbah; Smita Kohli; Sam Helgerson; Randall J Lee
Journal:  JACC Heart Fail       Date:  2013-06       Impact factor: 12.035

3.  Genetic Analysis of Connective Tissue Growth Factor as an Effector of Transforming Growth Factor β Signaling and Cardiac Remodeling.

Authors:  Federica Accornero; Jop H van Berlo; Robert N Correll; John W Elrod; Michelle A Sargent; Allen York; Joseph E Rabinowitz; Andrew Leask; Jeffery D Molkentin
Journal:  Mol Cell Biol       Date:  2015-04-13       Impact factor: 4.272

Review 4.  Myocardial Interstitial Fibrosis in Nonischemic Heart Disease, Part 3/4: JACC Focus Seminar.

Authors:  Javier Díez; Arantxa González; Jason C Kovacic
Journal:  J Am Coll Cardiol       Date:  2020-05-05       Impact factor: 24.094

5.  Cell death, tissue hypoxia and the progression of heart failure.

Authors:  H N Sabbah; V G Sharov; S Goldstein
Journal:  Heart Fail Rev       Date:  2000-06       Impact factor: 4.214

Review 6.  Left ventricular histomorphometric findings in dogs with heart failure treated with the Acorn Cardiac Support Device.

Authors:  Victor G Sharov; Anastassia V Todor; Hani N Sabbah
Journal:  Heart Fail Rev       Date:  2005-06       Impact factor: 4.214

7.  Cyclosporine A attenuates mitochondrial permeability transition and improves mitochondrial respiratory function in cardiomyocytes isolated from dogs with heart failure.

Authors:  Victor G Sharov; Anastassia Todor; Sanjaya Khanal; Makoto Imai; Hani N Sabbah
Journal:  J Mol Cell Cardiol       Date:  2006-10-27       Impact factor: 5.000

8.  Darbepoetin-alpha prevents progressive left ventricular dysfunction and remodeling in nonanemic dogs with heart failure.

Authors:  Sharad Rastogi; Makoto Imai; Victor G Sharov; Sudhish Mishra; Hani N Sabbah
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-10-24       Impact factor: 4.733

9.  Antifibrotic effect of Ac-SDKP and angiotensin-converting enzyme inhibition in hypertension.

Authors:  Saman Rasoul; Oscar A Carretero; Hongmei Peng; Maria A Cavasin; Jialong Zhuo; Alicia Sanchez-Mendoza; David R Brigstock; Nour-Eddine Rhaleb
Journal:  J Hypertens       Date:  2004-03       Impact factor: 4.844

Review 10.  Placental growth factor as a protective paracrine effector in the heart.

Authors:  Federica Accornero; Jeffery D Molkentin
Journal:  Trends Cardiovasc Med       Date:  2011-11       Impact factor: 6.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.